Teva to Host Innovation & Strategy Day on Thursday, May 29 in New York City
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has announced its upcoming Innovation & Strategy Day, scheduled for Thursday, May 29, 2025, in New York City. The event will run from 8:30 AM to 12:30 PM Eastern Time. CEO Richard Francis and the executive management team will present updates on the company's strategy, focusing on the acceleration phase, growth initiatives, and innovation priorities.
Due to limited capacity, in-person attendance is invitation-only, with analysts and institutional investors requiring pre-registration. A live webcast will be available on Teva's Investor Relations website, with archived content accessible within 24 hours after the event.
Teva Pharmaceutical Industries Ltd. (NYSE e TASE: TEVA) ha annunciato la prossima Innovation & Strategy Day, prevista per giovedì 29 maggio 2025 a New York City. L'evento si terrà dalle 8:30 alle 12:30 ora Eastern. Il CEO Richard Francis e il team esecutivo presenteranno aggiornamenti sulla strategia aziendale, con un focus sulla fase di accelerazione, le iniziative di crescita e le priorità di innovazione.
Per via della capacità limitata, la partecipazione in presenza è solo su invito, mentre analisti e investitori istituzionali devono preregistrarsi. Sarà disponibile una diretta streaming sul sito web Investor Relations di Teva, con i contenuti archiviati accessibili entro 24 ore dall'evento.
Teva Pharmaceutical Industries Ltd. (NYSE y TASE: TEVA) ha anunciado su próximo Innovation & Strategy Day, programado para el jueves 29 de mayo de 2025 en la ciudad de Nueva York. El evento se llevará a cabo de 8:30 AM a 12:30 PM hora del Este. El CEO Richard Francis y el equipo ejecutivo presentarán actualizaciones sobre la estrategia de la compañía, enfocándose en la fase de aceleración, las iniciativas de crecimiento y las prioridades de innovación.
Debido a la capacidad limitada, la asistencia presencial es solo con invitación, y los analistas e inversores institucionales deben preregistrarse. Habrá una transmisión en vivo disponible en el sitio web de Relaciones con Inversores de Teva, con contenido archivado accesible dentro de las 24 horas posteriores al evento.
Teva Pharmaceutical Industries Ltd. (NYSE 및 TASE: TEVA)는 2025년 5월 29일 목요일, 뉴욕시에서 개최되는 Innovation & Strategy Day 일정을 발표했습니다. 행사는 동부 표준시 기준 오전 8시 30분부터 오후 12시 30분까지 진행됩니다. CEO 리차드 프랜시스와 경영진 팀이 회사 전략에 대한 최신 정보, 가속화 단계, 성장 이니셔티브 및 혁신 우선순위에 대해 발표할 예정입니다.
참석 인원이 제한되어 있어 현장 참석은 초대받은 분들만 가능하며, 애널리스트 및 기관 투자자는 사전 등록이 필요합니다. Teva 투자자 관계 웹사이트에서 라이브 웹캐스트가 제공되며, 행사 후 24시간 이내에 아카이브된 콘텐츠도 이용할 수 있습니다.
Teva Pharmaceutical Industries Ltd. (NYSE et TASE : TEVA) a annoncé sa prochaine Innovation & Strategy Day, prévue le jeudi 29 mai 2025 à New York. L'événement se déroulera de 8h30 à 12h30 heure de l'Est. Le PDG Richard Francis et l'équipe de direction présenteront des mises à jour sur la stratégie de l'entreprise, en mettant l'accent sur la phase d'accélération, les initiatives de croissance et les priorités en matière d'innovation.
En raison de la capacité limitée, la participation en personne est sur invitation uniquement, et les analystes ainsi que les investisseurs institutionnels doivent s'inscrire à l'avance. Une webdiffusion en direct sera disponible sur le site des Relations Investisseurs de Teva, avec un contenu archivé accessible dans les 24 heures suivant l'événement.
Teva Pharmaceutical Industries Ltd. (NYSE und TASE: TEVA) hat seinen bevorstehenden Innovation & Strategy Day angekündigt, der am Donnerstag, den 29. Mai 2025, in New York City stattfindet. Die Veranstaltung läuft von 8:30 bis 12:30 Uhr Eastern Time. CEO Richard Francis und das Führungsteam werden Updates zur Unternehmensstrategie präsentieren, mit Fokus auf die Beschleunigungsphase, Wachstumsinitiativen und Innovationsprioritäten.
Aufgrund begrenzter Kapazitäten ist eine persönliche Teilnahme nur auf Einladung möglich, Analysten und institutionelle Investoren müssen sich vorab registrieren. Ein Live-Webcast wird auf der Investor-Relations-Website von Teva verfügbar sein, mit archivierten Inhalten, die innerhalb von 24 Stunden nach der Veranstaltung abrufbar sind.
- None.
- None.
TEL AVIV, Israel, May 07, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will host Innovation & Strategy Day on Thursday, May 29, 2025 to discuss the acceleration phase of its strategy and portfolio priorities. The event will take place in New York, N.Y. Presentations will begin at 8:30 a.m. Eastern Time and are expected to conclude at 12:30 p.m. Eastern Time.
Richard Francis, Teva's President and CEO, along with other members of the executive management team will discuss an update on the strategy and key priorities focusing on growth and innovation.
Due to limited capacity, in-person attendance is by invitation only. Analysts and institutional investors will be invited to pre-register and attend through an invite that will is distributed separately.
For questions regarding the event, please contact Teva's Investor Relations team at TevaIR@Tevapharm.com.
A live webcast of the event and presentation materials will be available on Teva's Investor Relations website at: https://ir.tevapharm.com/Events-and-Presentations.
An archived version of the webcast will be available within 24 hours after the end of the live discussion.
About Teva
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a different kind of global biopharmaceutical leader, one that operates across the full spectrum of innovation to reliably deliver medicines to patients worldwide. For over 120 years, Teva’s commitment to bettering health has never wavered. Today, the company’s global network of capabilities enables its 37,000 employees across 57 markets to advance health by developing medicines for the future while championing the production of generics and biologics. We are dedicated to addressing patients’ needs, now and in the future. Moving forward together with science that treats, inspired by the people we serve. To learn more about how Teva is all in for better health, visit www.tevapharm.com.
Cautionary Note Regarding Forward-Looking Statements
This press release and the conference call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management’s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. Important factors that could cause or contribute to such differences include risks relating to: our ability to successfully compete in the marketplace including our ability to successfully execute our Pivot to Growth strategy; our significant indebtedness; our business and operations in general; compliance, regulatory and litigation matters; other financial and economic risks; and other factors discussed in this press release, in our Annual Report on Form 10-K for the year ended December 31, 2024, including in the sections captioned "Risk Factors” and "Forward-looking Statements.” Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.
FAQ
When is Teva's (TEVA) Innovation & Strategy Day 2025?
Who can attend Teva's Innovation & Strategy Day 2025?
How can I watch Teva's Innovation & Strategy Day 2025?
What topics will be discussed at Teva's Innovation & Strategy Day 2025?
